Recruiting
Phase 3

Intravesical BCG vs GEMDOCE in NMIBC

Sponsor:

ECOG-ACRIN Cancer Research Group

Code:

NCT05538663

Conditions

Non-muscle-invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gemcitabine

Docetaxel

Bacillus Calmette Guerin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information